Your browser doesn't support javascript.
loading
[Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer]. / Confronto tra ranitidina, famotidina e omeprazolo nel trattamento dell'ulcera duodenale sanguinante.
Maculotti, L; Pradella, P.
Affiliation
  • Maculotti L; Divisione di Chirurgia Generale Andrea Ponti, Ospedale Niguarda Ca' Granda, Milano.
Minerva Chir ; 50(3): 279-81, 1995 Mar.
Article in It | MEDLINE | ID: mdl-7659265
ABSTRACT
A trial was carried out to compare the efficacy and safety of ranitidine 300 mg die, famotidine 40 mg die and omeprazole 20 mg die in short-term treatment of bleeding duodenal ulcer in 3 groups of 15 patients. The healing rates after 2.4 weeks were 33.60% respectively with ranitidine, 40, 70% respectively with famotidine and 53, 93% respectively with omeprazole. All the drugs were well tolerated and the adverse events were infrequent and moderate. The recurrence rates after 6, 12 months were 20, 33% respectively with ranitidine, 13, 20% respectively with famotidine and only 7, 13% respectively with omeprazole. In our experience, omeprazole seems to be superior to famotidine and to ranitidine in the short-term treatment of bleeding duodenal ulcer, with the shortest relapse rate.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ranitidine / Omeprazole / Famotidine / Peptic Ulcer Hemorrhage / Duodenal Ulcer Type of study: Clinical_trials Limits: Humans Language: It Journal: Minerva Chir Year: 1995 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ranitidine / Omeprazole / Famotidine / Peptic Ulcer Hemorrhage / Duodenal Ulcer Type of study: Clinical_trials Limits: Humans Language: It Journal: Minerva Chir Year: 1995 Document type: Article